Skip to search formSkip to main contentSkip to account menu

cytosine nucleoside

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
PurposeTroxacitabine (BCH-4556, l-(−)-OddC, Troxatyl) is a novel β-l-nucleoside analogue with potent antineoplastic activity both… 
2002
2002
Naturally occurring drug resistance genes of human origin can be exploited for selection of genetically engineered cells co… 
2000
2000
Hematopoietic toxicity is the dose-limiting side effect produced in cancer chemotherapy with deoxycytidine nucleoside analogs… 
Review
1997
Review
1997
5-Aza-2′-deoxycytidine (5-Aza-CdR; Decitabine) is an active antineoplastic agent in patients with leukemia. Since 5-Aza-CdR is an… 
1994
1994
The enzyme cytidine deaminase (EC 3.5.4.12; CDA) catalyzes the hydrolytic deamination of cytidine or deoxycytidine to uridine or… 
1989
1989
A previous report on the influence of a 6-methyl substituent on cytosine nucleoside degradation proposed that N-glycosyl… 
1986
1986
Carbocyclic analogues of 5-halocytosine nucleosides were prepared by direct halogenation of the carbocyclic analogues of cytidine… 
1974
1974
IV. ANTIMYCOPLASMA ACTIVITY OF ASPICULAMYCIN in vitro AND IN VIVOkn-subtitle=en-abstract=Aspiculamycin, a new cytosine nucleoside…